Wrapping up another great day at ESMO - European Society for Medical Oncology Congress! Ettai Markovits, Ken Bloom, and Abhishek Aggarwal from Gilead Sciences were on hand to discuss the latest results from our head and neck study, revealing key spatial differences between HPV+ and HPV- patients that could serve as predictive biomarkers for therapy. Did you catch our poster? Meet us to learn more! https://hubs.li/Q02PVrnM0 #ESMO24 #SpatialBiomarkers #AIPathology #DigitalPathology #biomarkers #PrecisionMedicine
Nucleai
Software Development
Chicago, IL 16,289 followers
The leading Spatial Biology Software Platform for Precision Medicine.
About us
Nucleai Brings AI-powered spatial biology technology to the forefront of precision medicine to improve drug development, clinical treatment decisions, and patient outcomes. Nucleai works with leading pharmaceutical companies, licensing its research platform for internal use, and collaborating in biomarkers discovery projects. Nucleai’s Atom: The leading Spatial Biology Platform for Precision Medicine.
- Website
-
https://nucleai.ai/
External link for Nucleai
- Industry
- Software Development
- Company size
- 51-200 employees
- Headquarters
- Chicago, IL
- Type
- Privately Held
- Founded
- 2018
- Specialties
- Pharma, Biomarker Development, Biomarker Discovery, Big Data, Machine Learning, CDx, Digital Pathology, Immunotherapy, Spatial biology, and Precision Medicine
Locations
-
Primary
Chicago, IL, US
Employees at Nucleai
Updates
-
The Nucleai team is heading to Barcelona this weekend for the ESMO - European Society for Medical Oncology Congress. Meet our Head of Pathology, Ken Bloom, and Director of Biomedical Research, Ettai Markovits, to explore how AI spatial biomarkers and diagnostics are powering next-gen therapies. Book a meeting here ➡️https://hubs.li/Q02PHkjv0 And be sure to join us for our poster session on Saturday, Sept 14, where we’ll be presenting our latest findings in collaboration with Gilead Sciences. 📍 Poster #916P - Deep spatial profiling of head and neck squamous cell carcinoma offers insights into the tumor microenvironment of hpv-stratified patients #ESMO #SpatialBiomarkers #AIPathology #biomarker #DigitalPathology #ESMO24
-
We are excited to share the latest findings from our head and neck study in collaboration with Gilead at ESMO - European Society for Medical Oncology Congress 2024. Our research reveals distinct tumor microenvironment patterns in HPV+ and HPV- patients, offering potential insights for future therapeutic approaches. Stop by our poster "Deep spatial profiling of head and neck squamous cell carcinoma offers insights into the tumor microenvironment of HPV-stratified patients" on Saturday, Sept 14 to meet our Head of Pathology, Ken Bloom and our Director of Biomedical Research, Ettai Markovits to learn how deep spatial profiling can offer actionable insights that may guide diagnostic and therapeutic decisions. View the abstract here 👇 https://hubs.li/Q02PtXy00 #ESMO24 #ESMO #SpatialBiomarker #biomarker #Immunotherapy #PrecisionMedicine #DigitalPathology
-
Did you catch Prof. O'Byrne's presentation at the World Lung Conference this weekend? Our collaborative research, led by Dr. Arutha Kulasinghe, Prof. Kenneth O'Byrne, and Dr. Ettai Markovits, has uncovered a metabolic signature in tumor cells linked to immunotherapy resistance and overall survival in lung cancer patients. This breakthrough could pave the way for predictive biomarkers for immune checkpoint inhibitors, marking a major step forward in cancer treatment. Learn more about this pivotal work and how it’s shaping the future of cancer care. 👉https://bit.ly/3Xk3oII #lungcancer #WCLC24 #NSCLC #biomarkers #spatialbiomarker #digitalpathology #immunotherapy
-
It was a pleasure to take part in Israel’s top tech and investor event, the #EY JournEY Israel Summit. Avi Veidman had the honor of joining an exceptional panel to discuss AI’s transformative role in healthcare and the real challenges of growing HealthTech startups. Big thanks to Yael Gruenbaum-Cohen for leading such a insightful conversation, and to Stephen Klasko for an inspiring keynote. Grateful to all the panelists and attendees for making this an outstanding event! #healthtech #AI #biotech #healthcare
I am honored to be a part of the #EY #Journey conference, one of Israel's top tech and investor events! The one and the only Stephen Klasko gave a tailored, swift, and inspiring keynote. Our panel (Great job driving this Yael Gruenbaum-Cohen!) had a great conversation about the real challenges of growing #HealthTech startups from both the #founder and #investor perspectives. We discussed #AI's impact on the future of healthcare and shared some honest insights. Big thanks to my fellow panelists and everyone who joined! Great event. Michal Tsur, Ronen Lavi, Ruthy Kaidar, Ari Shamiss, Tohar Meshulam Nucleai #aihealthcare
-
📢 We’re excited to showcase our research at the World Conference on Lung Cancer 2024, revealing a metabolic signature in tumor cells linked to immunotherapy resistance and overall survival in lung cancer patients. This breakthrough paves the way for developing predictive biomarkers for immune checkpoint inhibitors. Led by Dr. Arutha Kulasinghe and Prof. Ken O’Byrne, in collaboration with Dr. Ettai Markovits from Nucleai and Akoya Biosciences, Inc., this study marks a major advancement in cancer treatment. Nucleai is committed to driving innovation in cancer research and collaborating with leading scientists to translate these findings into tangible benefits for patients and healthcare providers worldwide. Read more: https://lnkd.in/grnJdNua Presentation Details: 𝗦𝗲𝘀𝘀𝗶𝗼𝗻 𝗢𝗔𝟬𝟯: Predicting the Future: Novel Pathology Assessments and Imaging Biomarkers 𝗣𝗿𝗲𝘀𝗲𝗻𝘁𝗮𝘁𝗶𝗼𝗻 𝗢𝗔𝟬𝟯.𝟬𝟲: "Deciphering Single-Cell Resolved Tumour Microenvironment Profiles Using Spatial Metabolic Mapping" 📅 Sunday, September 8, 2024, 🕛 11:17 am 📍 Room 32AB #WCLC24 #spatialbiomarkers #biomarkers #digitalpathology #immunotherapy #LungCancer #NSCLC
-
🎤 It was a full house and an incredible discussion at World CB & CDx! A big thank you to our panelists Christine K. Ward, PhD (Moderna), Mark Gustavson, PhD (AstraZeneca), and Rolando E. Yanes, PhD (Amgen) for sharing their expertise on AI & Digital Pathology – Enabling Next-Gen Treatments & Diagnostics. Your insights on how these technologies are shaping the future of drug development were invaluable. Want to learn more? Join the movement and learn how our AI-driven spatial biomarker solutions are advancing next-gen therapies. 🚀https://lnkd.in/g8EeSZQ9 #AIPathology #SpatialBiomarkers #WorldCDx2024 #Biomarkers #PrecisionMedicine #CDx #DigitalPathology #biomarkers Oscar Puig
-
🚨 𝐓𝐡𝐞 𝐩𝐚𝐧𝐞𝐥 𝐢𝐬 𝐭𝐨𝐦𝐨𝐫𝐫𝐨𝐰! Join top industry leaders as they explore how AI pathology is transforming next-gen therapies. See you at 2:15 PM ET! https://lnkd.in/g8EeSZQ9 #digitalpathology #aipathology #WorldCDx #WorldCDx2024 #CDx #Spatialbiomarkers
Heading to World CB & CDx next week? Be sure to catch our panel, "𝐀𝐈 𝐚𝐧𝐝 𝐃𝐢𝐠𝐢𝐭𝐚𝐥 𝐏𝐚𝐭𝐡𝐨𝐥𝐨𝐠𝐲 – 𝐄𝐧𝐚𝐛𝐥𝐢𝐧𝐠 𝐍𝐞𝐱𝐭-𝐆𝐞𝐧 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭𝐬 & 𝐃𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜𝐬," on Friday, September 6, at 2:15 pm ET. Our VP of Translational Medicine and Diagnostics, Oscar Puig, PhD, will lead a discussion with industry leaders Christine K. Ward , PhD (Moderna), Mark Gustavson , PhD (AstraZeneca), and Rolando E. Yanes, PhD , (Amgen) on how AI-powered pathology is transforming next-gen therapies. Join the movement and learn about the world's 𝒇𝒊𝒓𝒔𝒕 AI pathology solution for prospective trial enrollment. See you at Booth #9! https://lnkd.in/g8EeSZQ9 #AIPathology #digitalpathology #WorldCDx2024 #spatialbiomarkers #biomarkers #precisionmedicine
-
Huge thanks to Startup Nation Central for hosting the Gateway to Health Tech meetup! We loved being part of it and contributing to Israel's health tech community.
At this week’s Gateway to Health Tech meetup, Avi Veidman, CEO of Nucleai, shared how witnessing the challenges faced by pathologists, including the overwhelming workload and slow diagnostic timelines, inspired his company to develop groundbreaking AI-powered pathology solutions. Nucleai's work in precision medicine, made possible by the invaluable contributions of pathologists, demonstrates the crucial need for physicians to collaborate with technologists for better health outcomes. Following this, a dynamic panel discussion and breakout sessions offered insights from health tech trailblazers including: Haim Cohen, VP of Business Development at Datos Health Michal Tzuchman Katz, MD, CEO & Co-founder of Kahun David Lazerson, Co-founder & CEO of Briya Eran Hertzmann, VP Product & Ohad Pollack, CMO of TytoCare These industry leaders shared their unique perspectives on the challenges and opportunities for physicians to collaborate in health tech innovation, from developing AI-driven diagnostic tools to enhancing remote patient monitoring. A big thank you to all participants for making this event a success and for their unwavering commitment to building a stronger, more connected health tech ecosystem that empowers technologists, physicians, and ultimately, patients. Learn more about Gateway to Health Tech and how we are giving physicians the opportunity to become active contributors to Israel’s health tech ecosystem. 👉https://okt.to/OmJNPE Yahalom Bukai Herzel, Shiri Borenshtein, Yael Pomerantz, Chanel Itzhaki Ganor, Ortal Cohen, Noga Shiloach, Nitzan Frankel, Arnon Benor Iris Adler, MD #Healthcare #Innovation #IsraeliTech #AIinhealthcare #gatewaytohealthtech #StartupNation
-
We’re thrilled to be in San Diego this weekend for the World Conference on Lung Cancer 2024! 🎉 Meet us to discuss our AI pathology and spatial biomarker solutions for clinical trials and diagnostics. Discover how these innovations are driving the future of cancer care—let’s connect at WCLC! Stay tuned for more exciting news. 🚀 https://bit.ly/3Xz9KWc #WCLC24 #SpatialBiomarkers #biomarkers #PrecisionMedicine #Immunotherapy #DigitalPathology #LungCancer Martin Koch